MA35010B1 - Inhibiteurs de la peptide déformylase - Google Patents

Inhibiteurs de la peptide déformylase

Info

Publication number
MA35010B1
MA35010B1 MA36280A MA36280A MA35010B1 MA 35010 B1 MA35010 B1 MA 35010B1 MA 36280 A MA36280 A MA 36280A MA 36280 A MA36280 A MA 36280A MA 35010 B1 MA35010 B1 MA 35010B1
Authority
MA
Morocco
Prior art keywords
inhibitors
peptide deformylase
compound
bacterial
deformylase
Prior art date
Application number
MA36280A
Other languages
English (en)
Inventor
Kelly M Aubart
Andrew B Benowitz
Yuhong Fang
James Hoffman
Joseph M Karpinski
Andrew Nicholson Knox
Xiangmin Liao
Donghui Qin
Dongchuan Shi
Jared T Spletstoser
Original Assignee
Glaxosmithkline Ip No 2 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip No 2 Ltd filed Critical Glaxosmithkline Ip No 2 Ltd
Publication of MA35010B1 publication Critical patent/MA35010B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01088—Peptide deformylase (3.5.1.88)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Cette invention concerne un composé de formule (I), ou son sel pharmaceutiquement acceptable, des compositions pharmaceutiques correspondantes, la préparation du composé et des méthodes de traitement concernant les infections bactériennes et l'inhibition de l'activité de la peptide déformylase (PDF) bactérienne.
MA36280A 2011-03-09 2012-03-09 Inhibiteurs de la peptide déformylase MA35010B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161450784P 2011-03-09 2011-03-09
PCT/US2012/028424 WO2012122450A2 (fr) 2011-03-09 2012-03-09 Inhibiteurs de la peptide déformylase

Publications (1)

Publication Number Publication Date
MA35010B1 true MA35010B1 (fr) 2014-04-03

Family

ID=46798826

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36280A MA35010B1 (fr) 2011-03-09 2012-03-09 Inhibiteurs de la peptide déformylase

Country Status (23)

Country Link
US (1) US8901119B2 (fr)
EP (1) EP2684039A4 (fr)
JP (1) JP2014516917A (fr)
KR (1) KR20140011362A (fr)
CN (1) CN103827665A (fr)
AR (1) AR085698A1 (fr)
AU (1) AU2012225365A1 (fr)
BR (1) BR112013023057A2 (fr)
CA (1) CA2829361A1 (fr)
CL (1) CL2013002584A1 (fr)
CO (1) CO6761343A2 (fr)
CR (1) CR20130522A (fr)
DO (1) DOP2013000206A (fr)
EA (1) EA201391299A1 (fr)
MA (1) MA35010B1 (fr)
MX (1) MX2013010339A (fr)
PE (1) PE20140439A1 (fr)
PH (1) PH12013501830A1 (fr)
SG (1) SG192948A1 (fr)
TW (1) TW201249824A (fr)
UY (1) UY33939A (fr)
WO (1) WO2012122450A2 (fr)
ZA (1) ZA201306415B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101383565B1 (ko) 2013-03-21 2014-04-09 박용희 고효율 해수 증발 장치 및 증발로프 모듈
GB201409536D0 (en) 2014-05-29 2014-07-16 Univ The Durham Chemically modifying peptides
CN109851614B (zh) * 2019-03-29 2023-01-13 中山大学 一类杂环类肽脱甲酰基酶抑制剂及其制备方法和应用
CN122374291A (zh) 2023-12-12 2026-07-10 爱杜西亚药品有限公司 作为食欲素受体调节剂的芳基砜及砜酮衍生物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250700A (en) 1991-05-01 1993-10-05 American Home Products Corporation Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
US5399708A (en) 1993-11-12 1995-03-21 Eli Lilly And Company Pyrazolidin-3-one derivatives
UY27813A1 (es) * 2002-05-31 2003-12-31 Smithkline Beecham Corp Inhibidores de la peptido-desformilasa
WO2004087696A1 (fr) * 2003-04-03 2004-10-14 Merck Patent Gmbh Derives de l'acide pyrazolidine-1,2-dicarboxylique-1-(phenylamide)-2-(phenylamide) comme inhibiteurs du facteur de coagulation xa dans le traitement de thromboses
AU2006255084A1 (en) * 2005-06-08 2006-12-14 Novartis Ag Organic compounds
WO2007106670A2 (fr) * 2006-03-03 2007-09-20 Novartis Ag Composes de n-formyle hydroxylamine
UA108596C2 (xx) * 2007-11-09 2015-05-25 Інгібітори пептиддеформілази
CN101584694B (zh) * 2009-06-15 2011-01-12 华东师范大学 含2,5-二氢吡咯的肽脱甲酰基酶抑制剂及合成方法
JP5931724B2 (ja) * 2009-06-29 2016-06-08 ジェノセア バイオサイエンシーズ， インコーポレイテッド ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｎｅｕｍｏｎｉａｅに対するワクチンおよび組成物

Also Published As

Publication number Publication date
WO2012122450A3 (fr) 2014-04-03
CA2829361A1 (fr) 2012-09-13
EA201391299A1 (ru) 2014-02-28
AU2012225365A8 (en) 2013-09-19
AR085698A1 (es) 2013-10-23
CL2013002584A1 (es) 2014-02-21
PE20140439A1 (es) 2014-05-04
JP2014516917A (ja) 2014-07-17
MX2013010339A (es) 2013-10-03
ZA201306415B (en) 2014-04-30
CN103827665A (zh) 2014-05-28
AU2012225365A1 (en) 2013-09-12
CO6761343A2 (es) 2013-09-30
EP2684039A2 (fr) 2014-01-15
EP2684039A4 (fr) 2015-03-11
KR20140011362A (ko) 2014-01-28
CR20130522A (es) 2014-05-02
US20130345120A1 (en) 2013-12-26
SG192948A1 (en) 2013-09-30
BR112013023057A2 (pt) 2016-08-02
WO2012122450A2 (fr) 2012-09-13
TW201249824A (en) 2012-12-16
UY33939A (es) 2012-09-28
DOP2013000206A (es) 2014-01-31
PH12013501830A1 (en) 2013-10-14
US8901119B2 (en) 2014-12-02

Similar Documents

Publication Publication Date Title
TN2015000391A1 (en) Compounds and compositions for the treatment of parasitic diseases
MA33745B1 (fr) Piperidines substituees qui accroissent l'activite de p53, et utilisation de ces composes
EA201691803A1 (ru) Ингибиторы калликреина плазмы человека
MX363127B (es) Derivados de benzotiofeno como inhibidores del receptor de estrogeno.
EA201290191A1 (ru) N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ
UA104489C2 (uk) Сполуки для лікування дисліпідемії та споріднених хвороб
PH12014500529A1 (en) Substituted n- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin c
EA201690752A1 (ru) Ингибиторы g12c kras
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
EA201100391A1 (ru) Соединения, ингибирующие активность семикарбазид-чувствительной аминооксидазы
PH12014500682A1 (en) 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
EA201500182A1 (ru) 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ
EA201300250A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
MA43052B1 (fr) Inhibiteurs de la kallicréine plasmatique humaine
WO2014151630A3 (fr) Composés et compositions pour le traitement de maladies parasitaires
EA201391018A1 (ru) Препараты иммуносупрессантов
PH12013500644A1 (en) Co-crystals and salts of ccr3-inhibitors
EA201991916A1 (ru) 1,4,6-ТРИЗАМЕЩЕННЫЕ-2-АЛКИЛ-1H-БЕНЗО[d]ИМИДАЗОЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ДИГИДРООРОТАТНЫХ ОКСИГЕНАЗНЫХ ИНГИБИТОРОВ
PH12016501198A1 (en) Compounds and compositions for the treatment of parasitic diseases
EA201490436A1 (ru) Антибактериальные 3,4-дигидро-1н-[1,8]нафтиридиноны, замещенные гомопиперидинилом
MA38679B1 (fr) Modulateurs du récepteur de cxcr7
EA201590074A1 (ru) Производное бензодиоксола, способ его получения и его применение
EA201391299A1 (ru) Ингибиторы пептиддеформилазы
MA34961B1 (fr) Inhibiteurs de la cathepsine c
PH12014501215A1 (en) Peptide deformylase inhibitors